Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters


TUMOUR-PROMOTING compounds are not themselves carcinogenic, but can induce skin tumours in mice pretreated with a subcarcinogenic dose of a chemical carcinogen1–3. They have been shown to produce many different biochemical and biological effects on cells3,4, but the mechanism of promotion is not known. Two recent reports describe the effects of the phorbol diester series of tumour promoters on cell differentiation in vitro. Cohen et al.5 observed that 12-O-tetradecanoyl-phorbol-13-acetate (TPA; phorbol myristate acetate), a potent promoter, inhibits myogenesis in chick embryo muscle cultures. We have reported6,7 that TPA and other tumour-promoting phorbol diesters inhibit spontaneous and induced differentiation of Friend erythroleukaemia cells in culture. We now describe another cell system, mouse preadipose cells, in which tumour promoters inhibit terminal differentiation, and confirm in these cells our original observation6 that there is a good correlation between the ability of a particular phorbol diester to promote tumours in mouse skin and its ability to inhibit terminal differentiation of cells in culture.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Van Duuren, B. L. Progr. exp. Tumor Res. 11, 31–68 (1969).

  2. 2

    Hecker, E. Methods Cancer Res. 6, 439–484 (1971).

  3. 3

    Boutwell, R. K., C.R.C. Crit. Rev. Toxic. 2, 419–443 (1974).

  4. 4

    Weinstein, I. B., Wigler, N. & Pietropaolo, C. in Cold Spring Harbor Symposium on the Origins of Human Cancer (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, in the press).

  5. 5

    Cohen, R., Pacïfici, M., Rubinstein, N., Biehl, J. & Holtzer, H. Nature 266, 538–540 (1977).

  6. 6

    Rovera, G., O'Brien, T. & Diamond, L. Proc. natn. Acad. Sci. U.S.A. 74, 2894–2898 (1977).

  7. 7

    Diamond, L., O'Brien, T. & Rovera, G. in Symposium on Mechanisms of Tumor Promotion and Cocarcinogenesis (Raven, New York, in the press).

  8. 8

    Quarles, J. M. & Tennant, R. W. Cancer Res. 35, 2637–2645 (1975).

  9. 9

    Green, H. & Kehinde, O. Cell 1, 113–116 (1974).

  10. 10

    Green, H. & Meuth, M. Cell, 3, 127–133 (1974).

  11. 11

    Green, H. & Kehinde, O. Cell 5, 19–27 (1975).

  12. 12

    Russell, T. R. & Ho, R-J. Proc. natn. Acad. Sci. U.S.A. 73, 4516–4520 (1976).

  13. 13

    Sivak, A. & Van Duuren, B. L. Cancer Res. 30, 1203–1205 (1970).

  14. 14

    Diamond, L., O'Brien, S., Donaldson, C. & Shimizu, Y. Int. J. Cancer 13, 721–730 (1974).

  15. 15

    Thielmann, H. W. & Hecker, E. in Fortschritte der Krebsforschung (eds Schmidt, C. G. & Wetter, O.) 171–179 (Schattauer, Stuttgart and New York, 1969).

  16. 16

    Baird, W. M. & Boutwell, R. K. Cancer Res. 31, 1074–1079 (1971).

  17. 17

    Raick, A. N. Cancer Res. 34, 2915–2925 (1974).

  18. 18

    Marks, F. Cancer Res. 36, 2636–2643 (1976).

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

DIAMOND, L., O'BRIEN, T. & ROVERA, G. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters. Nature 269, 247–249 (1977).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.